Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

acare ehf. - paracetamolum inn; ibuprofenum inn - filmuhúðuð tafla - 200/500 mg

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - paracetamolum inn - endaþarmsstíll - 500 mg

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - paracetamolum inn - endaþarmsstíll - 125 mg

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - paracetamolum inn - endaþarmsstíll - 250 mg

Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

sandoz gmbh - natalízúmab - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 og 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

zentiva k.s.* - desmopressinum acetat - tungurótartafla - 120 míkróg

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

zentiva k.s.* - desmopressinum acetat - tungurótartafla - 240 míkróg

Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

zentiva k.s.* - lactose monohydrate; desmopressinum acetat - tungurótartafla - 60 míkróg

Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

mylan pharmaceuticals limited - meðferð besilate, valsartan - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - meðferð við nauðsynlegum háþrýstingi. meðferð/valsartan mylan er ætlað í fullorðnir sem blóðþrýstingur er ekki nægilega stjórn á meðferð eða valsartan sér.

Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - skert umbrot brómíð, trifenatate. - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - Þar ellipta er ætlað sem viðhald berkjuvíkkandi meðferð til að létta einkenni í fullorðinn sjúklinga með langvinn veikindi í lungum (llt).